World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
16286
World Ranking
3297
National Ranking
152

Erika Vacchelli publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Erika Vacchelli sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 92 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Erika Vacchelli D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Erika Vacchelli sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Erika Vacchelli is affiliated with Université Paris Cité in France. Their research focuses primarily on biochemistry, genetics and molecular biology, medicine, and immunology and microbiology, with a total of 15, 14, and 12 publications respectively in these fields.

The scientist's work extensively covers several specialized subfields including immunology, molecular biology, oncology, pharmacology, and infectious diseases. Key topics addressed in their research include S100 proteins and annexins, interferon and immune responses, immune response and inflammation, immunotherapy and immune responses, cancer immunotherapy and biomarkers, biomarkers in disease mechanisms, and cannabis and cannabinoid research.

Erika Vacchelli has contributed to various academic journals, with a notable concentration of publications in OncoImmunology, totaling 10 papers. Other venues where their work appears include Cancer Discovery, Cell Death and Differentiation, Cell Death Discovery, and Neural Computing and Applications.

Their frequent coauthors in research collaborations are:

  • Guido Kroemer (15 collaborations)
  • Julie Le Naour (12 collaborations)
  • Laurence Zitvogel (5 collaborations)
  • Lorenzo Galluzzi (5 collaborations)
  • Allan Sauvat (5 collaborations)

Recent publications authored or coauthored by Erika Vacchelli include:

  • "Trial watch: STING agonists in cancer therapy", 2020, OncoImmunology
  • "Trial watch: TLR3 agonists in cancer therapy", 2020, OncoImmunology
  • "Trial watch: IDO inhibitors in cancer therapy", 2020, OncoImmunology
  • "Trial Watch: experimental TLR7/TLR8 agonists for oncological indications", 2020, OncoImmunology
  • "A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency", 2020, Cancer Discovery

This body of work reflects an emphasis on cancer immunotherapy and the development of immune modulatory strategies targeting toll-like receptors and other agents involved in oncological therapies.

Best Publications

  • Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.

    Mickaël Michaud;Mickaël Michaud;Mickaël Michaud;Isabelle Martins;Isabelle Martins;Isabelle Martins;Abdul Qader Sukkurwala;Abdul Qader Sukkurwala;Abdul Qader Sukkurwala;Sandy Adjemian;Sandy Adjemian;Sandy Adjemian

  • Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

    Antonella Sistigu;Takahiro Yamazaki;Erika Vacchelli;Kariman Chaba

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

  • Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.

    Yuting Ma;Yuting Ma;Yuting Ma;Sandy Adjemian;Sandy Adjemian;Sandy Adjemian;Stephen R. Mattarollo;Takahiro Yamazaki;Takahiro Yamazaki;Takahiro Yamazaki

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

    Federico Pietrocola;Federico Pietrocola;Jonathan Pol;Erika Vacchelli;Erika Vacchelli;Shuan Rao

  • Regulation of Autophagy by Cytosolic Acetyl-Coenzyme A

    Guillermo Mariño;Federico Pietrocola;Tobias Eisenberg;Yongli Kong

  • Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death

    Laurie Menger;Erika Vacchelli;Erika Vacchelli;Erika Vacchelli;Sandy Adjemian;Sandy Adjemian;Sandy Adjemian;Isabelle Martins;Isabelle Martins;Isabelle Martins

  • Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1

    Erika Vacchelli;Yuting Ma;Elisa E. Baracco;Antonella Sistigu

  • Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

    Abhishek D. Garg;Lorenzo Galluzzi;Lionel Apetoh;Lionel Apetoh;Thais Baert

  • Mitochondrial gateways to cancer.

    Lorenzo Galluzzi;Eugenia Morselli;Eugenia Morselli;Oliver Kepp;Oliver Kepp;Ilio Vitale;Ilio Vitale

  • Trial watch: IDO inhibitors in cancer therapy

    Erika Vacchelli;Fernando Aranda;Alexander Eggermont;Catherine Sautès-Fridman

  • Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy.

    Jonathan Pol;Erika Vacchelli;Fernando Aranda;Francesca Castoldi

  • Regulation of autophagy by stress-responsive transcription factors.

    Federico Pietrocola;Valentina Izzo;Mireia Niso-Santano;Mireia Niso-Santano;Erika Vacchelli;Erika Vacchelli

  • Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

    Laura Senovilla;Erika Vacchelli;Jerome Galon;Sandy Adjemian

  • Crizotinib-induced immunogenic cell death in non-small cell lung cancer

    Peng Liu;Liwei Zhao;Jonathan Pol;Sarah Levesque

  • Trial watch

    Unknown

  • Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.

    Erika Vacchelli;Lorenzo Galluzzi;Alexander Eggermont;Wolf Hervé Fridman

  • Trial watch: Chemotherapy with immunogenic cell death inducers.

    Erika Vacchelli;Laura Senovilla;Alexander Eggermont;Wolf Hervé Fridman

  • Trial watch: Oncolytic viruses for cancer therapy

    Erika Vacchelli;Alexander Eggermont;Catherine Sautès-Fridman;Jérôme Galon

  • Trial watch: Dendritic cell-based interventions for cancer therapy.

    Erika Vacchelli;Ilio Vitale;Alexander Eggermont;Wolf Hervé Fridman

Frequent Co-Authors

Guido Kroemer
Guido Kroemer Université Paris Cité
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay
Oliver Kepp
Oliver Kepp Institut Gustave Roussy
Isabelle Martins
Isabelle Martins Inserm : Institut national de la santé et de la recherche médicale
Laura Senovilla
Laura Senovilla University of Valladolid
Alexander M.M. Eggermont
Alexander M.M. Eggermont Institut Gustave Roussy
Federico Pietrocola
Federico Pietrocola Karolinska Institute
Yuting Ma
Yuting Ma University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring allied health and nursing pathways can be a practical step. Programs such as accredited lpn programs easy to get into offer accessible entry points into healthcare, providing foundational knowledge useful in immunology-related settings.

Moving forward, one might consider advancing to roles like nurse practitioners. The easiest nurse practitioner degree programs provide streamlined options for registered nurses seeking graduate-level qualifications with flexibility and supportive curricula.

For those drawn to mental health, specifically the intersection with immunological factors, exploring best psychiatric mental health nurse practitioner programs online can be invaluable. These programs often offer excellent clinical placement rates to gain real-world experience.

Cost can be a concern, so researching cheapest psychiatric nurse practitioner programs enables prospective students to find budget-friendly options without compromising quality.

Overall, these related online degrees open diverse career pathways that complement immunology knowledge, combining scientific understanding with practical healthcare skills.

Best Scientists Citing Erika Vacchelli

Trending Scientists

Recently Published Articles